Search - tctmd.com

Displaying 121 - 128 of 128

Sort: Relevancy | Date

Presentation TCT 2013

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Presenter: Gunnar Tepe

October 31, 2013

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

Presentation TCT 2013

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Presenter: Clemens von Birgelen

October 28, 2013

Presentation TCT 2013

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Presenter: Lisette Okkels Jensen

October 28, 2013

Presentation TCT 2013

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

Presenter: Peter Smits

October 28, 2013

Presentation TCT 2013

The Spectrum of Current and Future Renal Denervation Clinical Trials

Presenter: Mehdi Shishehbor

October 27, 2013

Presentation TCT 2012

A View to Future Trials: HORIZONS-AMI II and Others

Presenter: Roxana Mehran

October 24, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Advertisement

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

The Spectrum of Current and Future Renal Denervation Clinical Trials

A View to Future Trials: HORIZONS-AMI II and Others

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content